Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SK pseudogene 96 is a processed pseudogene in the human genome located on chromosome 4[3][4][5]. Unlike its functional parent, RN7SK, which encodes a regulatory non-coding RNA involved in transcriptional regulation via sequestration of transcription elongation factors, this pseudogene does not produce functional RNA or protein products and has not been linked to biological activity or disease processes[3][4]. No drugs or therapeutics are directed at this pseudogene. The functional gene, RN7SK, is part of 7SK snRNP that regulates transcription; however, RN7SKP96 is an inactive, non-functional genetic relic without therapeutic or clinical significance[1][2][3]. Pseudogenes like RN7SKP96 are typically not considered targets for drug development or clinical intervention[3][4][5]. If you are seeking a functional therapeutic target, the parental gene RN7SK/RNA, 7SK small nuclear RNA, would be the relevant entity, not RN7SK pseudogene 96.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RN7SK pseudogene 96 (RN7SKP96).